NCT00352482View on ClinicalTrials.gov

Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

July 31, 2007

Conditions

Pulmonary FibrosisHypertension, Pulmonary

Interventions

DRUG

Sildenafil (50 mg)

Trial Locations (1)

90095

UCLA Pulmonary Outpatient Clinic,, Los Angeles

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00352482 - Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension | Biotech Hunter | Biotech Hunter